Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDREP: Hydroxyurea Impact on Spermatogenesis in Sickle Cell Disease
NCT01609192Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyurea in sickle cell disease (SCD), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2010; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01609192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609192.